Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets

The Journal of Clinical Investigation
K J KaoP A McKee


The presence of specific Factor VIII/von Willebrand factor (FVIII/vWF) binding sites on human platelets has been demonstrated by using 125I-FVIII/vWF and washed human platelets. Binding is ristocetin-dependent and increases in proportion to the concentration of ristocetin from 0.2 to 1 mg/ml. Binding of 125I-FVIII/vWF to platelets can be competitively inhibited by unlabeled human or bovine FVIII/vWF, but not by human thrombin, fibrinogen, alpha 2-macroglobulin, equine collagen, or a lectin of Ricinus communis. Scatchard analysis of binding data indicated that the dissociation constant of FVIII/vWF receptors is 0.45--0.5 nM. There are 31,000 binding sites per platelet at 1 mg/ml of ristocetin concentration. The optimal pH range for binding is from 7.0 to 7.5. At a concentration of 2 mM, EGTA inhibits 86% of the binding; however, 20 mM of Ca++, Mg++, or EDTA have little effect. Binding sites for FVIII/vWF were found only on platelets, and no significant binding was detected with human erythrocytes or polymorphonuclear leukocytes.


Jan 1, 1977·The Journal of Clinical Investigation·R L NachmanB B Weksler
Apr 1, 1977·British Journal of Haematology·M B ZuckerR A Grant
May 1, 1978·The Journal of Clinical Investigation·B S Coller
Aug 1, 1975·The Journal of Clinical Investigation·E P Kirby, D C Mills
Mar 1, 1977·Analytical Biochemistry·R F BaughC Hougie
Apr 1, 1976·The Journal of Clinical Investigation·M E Switzer, P A McKee
May 1, 1975·The Journal of Experimental Medicine·R L Nachman, E A Jaffe
Sep 1, 1973·The Journal of Clinical Investigation·G A ShapiroP A McKee
Feb 26, 1974·Biochemistry·G S David, R A Reisfeld
Apr 29, 1974·Biochimica Et Biophysica Acta·J H Greenberg, G A Jamieson


Jun 19, 1986·Biochimica Et Biophysica Acta·J A Malinski, G L Nelsestuen
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·K J KaoP A McKee
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·Z M RuggeriL De Marco
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J S BennettD B Cines
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S TimmonsJ Hawiger
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D D WagnerV J Marder
Feb 1, 1984·The Journal of Cell Biology·P E StenbergD F Bainton
May 1, 1983·British Journal of Haematology·D Meyer, H R Baumgartner
Aug 1, 1981·The Journal of Clinical Investigation·L De Marco, S S Shapiro
Jul 1, 1983·The Journal of Clinical Investigation·Z M RuggeriR R Montgomery
Feb 1, 1985·The Journal of Clinical Investigation·G Di MinnoM Mancini
Feb 1, 1986·The Journal of Clinical Investigation·J TakamatsuH R Gralnick
Aug 1, 1986·The Journal of Clinical Investigation·P BockenstedtR I Handin
Mar 1, 1988·Journal of Periodontology·P J HanesG T Frederick
Feb 24, 2001·American Journal of Clinical Pathology·S S GrahamJ L Miller
Jan 1, 1986·Critical Reviews in Oncology/hematology·R J HamerJ J Sixma
Jun 1, 1984·Thrombosis Research·T J NokesR M Hardisty
Jun 15, 1985·Thrombosis Research·J M Kupinski, J L Miller
Aug 1, 1980·Thrombosis Research·Y LegrandJ P Caen
Apr 1, 1981·Thrombosis Research·J E Brown, L P Thuy
Feb 1, 1996·Journal of the American Academy of Dermatology·M L Wallace, B R Smoller
Dec 15, 1984·Thrombosis Research·T A Horbett, R B Counts
Aug 28, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Junmei ChenDominic W Chung
Jan 1, 1982·Annals of the New York Academy of Sciences·E A Jaffe
Jan 1, 1987·Annals of the New York Academy of Sciences·J Hawiger
Jan 1, 1987·Annals of the New York Academy of Sciences·D MeyerJ P Girma
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·J Lahav, R O Hynes
Jan 1, 1985·Annals of the New York Academy of Sciences·E A Jaffe
Feb 1, 1985·American Journal of Hematology·H TakahashiA Shibata

Related Concepts

Blood Coagulation Factor
Blood Platelets
Edetic Acid, Sodium Salt
Egtazic Acid Sodium Salt
Factor VIII Procoagulant Activity
Plasma Protein Binding Capacity
Plasma Factor VIII Complex

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.